477 related articles for article (PubMed ID: 15364214)
1. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
3. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
5. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
7. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
[TBL] [Abstract][Full Text] [Related]
8. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS.
Thorne JE; Holbrook JT; Jabs DA; Kempen JH; Nichols C; Meinert CL;
Ophthalmology; 2007 Mar; 114(3):591-8. PubMed ID: 17123624
[TBL] [Abstract][Full Text] [Related]
9. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A
Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
[TBL] [Abstract][Full Text] [Related]
12. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
16. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
Harrison JM; van Heuven WA
Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
[TBL] [Abstract][Full Text] [Related]
17. [Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
Moreno Ruiz O; Ferrer Novella E; Torrón Fernández C; Arazo Garcés P; Melcon Sánchez B; Honrubia López FM
Arch Soc Esp Oftalmol; 2001 Jul; 76(7):397-402. PubMed ID: 11438875
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
19. Long-term study of intraocular pressure changes in patients with human immunodeficiency virus treated with highly active antiretroviral therapy.
Kozak I; LaBree L; Azen SP; Cheng L; Reagan NL; Freeman WR
Ophthalmology; 2006 Mar; 113(3):451-5. PubMed ID: 16513459
[TBL] [Abstract][Full Text] [Related]
20. Results of silicone oil removal in patients with cytomegalovirus retinitis related retinal detachments.
Morrison VL; Labree LD; Azen SP; Goldberg DE; Freeman WR
Am J Ophthalmol; 2005 Nov; 140(5):786-793. PubMed ID: 16214100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]